Construction and Evaluation of Folic Acid-Modified 3-Bromopyruvate Cubosomes.
CONCLUSIONS It is possible to successfully construct 3BP-LCNP-FA as a drug delivery vehicle that is more efficacious than 3-bromopyruvate and has no obvious toxic effects. Thus, folic acid-modified cubosomes can be used as effective carriers for targeted drug administration.
PMID: 32956335 [PubMed - as supplied by publisher]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Chemotherapy | Folic Acid | Liver | Nanotechnology | PET Scan | Research | Science | Toxicology | Urology & Nephrology | Vitamin B9